Business Wire

OR-GUROBI-OPTIMIZATION

6.12.2022 15:02:17 CET | Business Wire | Press release

Share
Gurobi’s Expert-Led Team Provides In-Depth Technical Guidance and Support

Gurobi Optimization, LLC, the leader in decision intelligence technology and creator of the world’s fastest mathematical optimization solver, recently announced the rebranding of its support team as “Gurobi Experts – Technical Advisory and Support Team.” This team of 15+ PhD-level optimization specialists is passionate about helping customers succeed with optimization and can provide comprehensive guidance on Gurobi products and mathematical optimization.

Matthias Miltenberger, Optimization Support Manager, explained that the reasoning behind the rebrand stemmed from some common misunderstandings about the word “support.”

“There’s this idea that ‘support’ means sitting in a call center all day with headphones on,” said Miltenberger. “Most people hear that word and think of experiences they’ve had calling up their phone or internet provider, which are often unpleasant experiences. And the assumption is that they’re not really talking to experts, so we definitely wanted to change that mindset.”

Indeed, the work of the Expert Team extends far beyond basic support. With over 150 years of optimization experience between them, the team works across three continents and uses their expert knowledge to provide a variety of services to customers around the world, including:

  • Model troubleshooting: The Expert Team can help identify and troubleshoot unexpected problems, such as slow performance or code failure.
  • Performance tuning: Rather than relying on a trial-and-error approach, the Expert Team often uses their expert knowledge to anticipate how the solver might react to certain parameter changes, which saves valuable time for customers.
  • Outreach: On top of the virtual assistance they provide on a daily basis, they frequently attend conferences and events, where they teach attendees how to model problems, improve their models, and overcome many other common challenges. The team also shares their knowledge with Gurobi’s community forum, where customers can ask questions or share their own expertise.

“We’re people who care deeply about optimization and about helping our customers succeed,” explains Dr. Sonja Mars, who directs the team. “On any given day, you’ll see us digging deep into our customers’ complex installation questions, programming interfaces, performance tuning challenges, you name it.”

“In a nutshell, we help our customers get the most out of the Gurobi solver, which is a very complex and powerful product,” explained Miltenberger. “There’s the mathematical stuff, where you really need to understand what is happening inside the engine, but you also need to understand how to best use Gurobi on a variety of machine architectures.”

“Solving puzzles is what we do,” added Dr. Alison Cozad. “But what really excites me is working with customers. Understanding their problem, discussing with them, and then coming to a solution together—there’s nothing like it.”

Most customer communication with the Expert Team happens via email or a ticket system, which gives the team time to delve deep into an issue and find the best solution. However, the team is also available for video calls or screen-sharing sessions for issues that require more hands-on assistance. The team’s median first-reply time is just 27 minutes.

“We all love what we do,” explains Dr. Eli Towle. “Solving the most complex problems on the planet—where millions of trillions of possible solutions exist—in a short amount of time . . . that’s an exciting job.”

Gurobi customers appreciate the team’s personalized service, as well as the fact that the team can dedicate extra time to find solutions to complicated challenges. This is evidenced by their 98.5% positive customer satisfaction rating, as well as customer testimonials.

In addition to offering top-notch support, the Expert Team is constantly on the lookout for opportunities to innovate. Miltenberger recalls a case where one customer’s problem actually led to the development of a brand-new tool.

“For one particular customer with certain time constraints, I needed to come up with a new way of tuning their models. I saw this as an opportunity to create a new tool that makes it easier to complete all kinds of tuning requests. In the end, this solution turned into a software package called GRBlogtools, which the Expert Team now uses daily to analyze dozens or even hundreds of log files, to see if tweaking a parameter makes a difference in terms of performance.”

Learn more about how the Gurobi Expert Team uses its expertise to help users have the most successful optimization experience possible.

About Gurobi Optimization

With Gurobi’s decision intelligence technology, you can make optimal business decisions in seconds. From workforce scheduling, portfolio management, and marketing optimization, to supply chain design, and everything in between, Gurobi identifies your optimal solution, out of trillions of possibilities.

As the leader in decision intelligence, Gurobi delivers easy-to-integrate, full-featured software and best-in-class support, with an industry-leading 98% customer satisfaction rating.

Founded in 2008, Gurobi has operations across the Americas, Europe, and Asia. Over 2,500 global customers across 40+ industries run on Gurobi, including SAP, Air France, and the National Football League, as well as half of the Fortune 10 and 70% of top global tech companies. For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005457/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye